biomedicina slovenica


"ANTIBODIES" : 201-300

  1. Hočevar Alojzija; Ješe Rok; Rotar Žiga; Žigon Polona; Čučnik Saša; Tomšič Matija
    Antiphospoholipid antibodies in giant cell arteritis. What can they tell us?
    2016
  2. Kveder Tanja; Lakota Katja; Švec Tinka; Čučnik Saša; Žigon Polona; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Tomšič Matija
    Fluorometric immunoassay for detection of anti-dsDNA antibodies
    [Dosage immunologique fluorométrique pour la détection d'anticorps anti-adndb]
    2015
  3. Kärner Jaanika; Pihlap Maire; Ranki Annamari; Krohn Kai; Trebušak Podkrajšek Katarina; Bratanič Nevenka; Battelino Tadej; Willcox Nick; Peterson Pärt; Kisand Kai
    IL-6-specific autoantibodies among APECED and thymoma patients
    2016
  4. Meyer Steffen; Woodward Mark; Hertel Christina; Vlaicu Philip; Haque Yasmin; Trebušak Podkrajšek Katarina; Battelino Tadej; Bratanič Nevenka
    AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies
    2016
  5. Žigon Polona; Podovšovnik Anuška; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Gašperšič Nataša; Rotar Žiga; Praprotnik Sonja; Sodin-Šemrl Snežna; Čučnik Saša
    Added value of anti-phosphatidylserine/prothrombin antibodies for antiphospholipid syndome
    2016
  6. Jelen Mateja; Hošnjak Lea; Štunf Špela; Zagožen Anja; Fujs Komloš Kristina; Markočič Petra; Poljak Mario; Seme Katja
    Hepatitis D virus infection in Slovenian patients with chronic hepatitis B virus infection
    2016
  7. Lužnik Zala; Hawlina Marko; Maličev Elvira; Bertolin Marina; Kopitar Andreja Nataša; Ihan Alojz; Ferrari Stefano; Schollmayer Petra
    Effect of cryopreserved amniotic membrane orientation on the expression of limbal mesenchymal and epithelial stem cell markers in prolonged limbal explant cultures
    2016
  8. 19th Annual meeting of the European Society for Clinical Virology, Lisbon, 14-17 September 2016
    2016
  9. Čučnik Saša
    Imunokemijske značilnosti klinično pomembnih protiteles [beta]2-glikoproteinu I
    [Immunochemical properties of clinically relevant anti-[beta]2-glycoprotein I antibodies]
    2016
  10. Peyvandi Flora; Zver Samo
    ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
    2008
  11. Krähling Verena; Becker Dirk; Rohde Cornelius; Eickmann Markus; Ero&x11F;lu Yonca; Herwig Astrid; Kerber Romy; Kowalski Katharina; Vergara-Alert Júlia; Becker Stephan; Korva Miša; Avšič-Županc Tatjana
    Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus
    2016
  12. Bizjak Mojca; Bruck Or; Kadunc Darja; Praprotnik Sonja; Shoenfeld Yehuda
    Vaccinations and secondary immune thrombocytopenia with antiphospholipid antibodies by human papillomavirus vaccine
    2016
  13. Bizjak Mojca; Bruck Or; Praprotnik Sonja; Dahan Shani; Shoenfeld Yehuda
    Pancreatitis after human papillomavirus vaccination
    2016
  14. Sill Martin; Schröder Christoph; Shen Ying; Marzoq Aseel; Komel Radovan; Hoheisel Jörg; Nienhüser Henrik; Schmidt Thomas; Kastelic Damjana
    Protein profiling gastric cancer and neighboring control tissues using high-content antibody microarrays
    2016
  15. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    IGA antiphospholipid antibodies present a thrombotic risk in patients with systemic autoimmune diseases
    2016
  16. Fecková Barbora; Kimáková Patrícia; Ilkovičová Lenka; Szentpéteriová Erika; Debeljak Nataša; Solárová Zuzana; Sačková Veronika; Šemeláková Martina; Bhide Mangesh; Solár Peter
    Far-western blotting as a solution to the non-specificity of the anti-erythropoietin receptor antibody
    2016
  17. Raijmakers Reinout; van Beers Joyce J. B. C.; El-Azzouny Mahmoud; Visser Natasja F. C.; Božič Borut; Pruijn Ger J. M.
    Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients
    2012
  18. Premrov Bajuk Blanka; Furlan Tjaša; Černelč Peter; Čeh Marija; Podgornik Helena
    Monoclonal B-cell lymphocytosis in the population of Slovenian region of Lower Carniola
    2016
  19. Matos Erika
    Pomen določanja HER2 statusa pri raku dojke
    2010
  20. Ocvirk Janja
    Osnovni principi citostatskega in biološkega zdravljenja solidnih rakov
    2005
  21. Zakotnik Branko
    Vloga sistemskega zdravljenja v onkologiji
    2005
  22. Wenger M.; Jezeršek Novaković Barbara
    Rituximab maintenance therapy can be safely administered via a rapid infusin protocol
    2008
  23. Kotnik Mojca; Duratović Konjević Amela; Lokar Katarina; Bernot Marjana; Jezeršek Novaković Barbara; Pečnik Tjaša
    Izzivi sodobnih pristopov onkološke zdravstvene nege in zdravljenja
    2009
  24. Gorenc Nataša
    Izkušnje v zdravstveni negi bolnika, zdravljenega z bevacizumabom
    2009
  25. Bernot Marjana
    Zdravstvena nega bolnika pri pojavu neželenih učinkov sistemskega zdravljenja s tarčnim zdravilom bevacizumab
    2009
  26. Umičević Snežana
    Priprava, aplikacija in shranjevanje zdravila bevacizumab
    2009
  27. Ocvirk Janja
    Klinična uporaba zdravila bevacizumab v onkologiji
    2009
  28. Jovchevska Ivana; Kočevar Nina; Kastelic Damjana; Komel Radovan
    Llama heavy-chain antibodies as means to identify protein markers for human glioma
    2013
  29. Maličev Elvira; Kozak Matija; Rožman Primož
    Evaluation of a flow cytometric assay for the confirmation of heparin-induced thrombocytopenia
    2016
  30. Majcen-Vivod Božislava
    Seroprevalence of antibodies to hepatitis A virus in blood donors and patients in Maribor
    2008
  31. Jezeršek Novaković Barbara
    Checkpoint inhibitors in Hodgkin¼s lymphoma
    2016
  32. Škoberne Andrej
    Vloga protiteles proti fosfolipaza A2 receptorju pri patogenezi membranske nefropatije
    [The role of phospholipase A2 receptor autoantibodies in the pathogenesis of membranous nephropathy]
    2014
  33. Haines G. Kenneth; Frković-Grazio Snježana; Bračko Matej
    HER2 in well differentiated breast cancer
    2008
  34. Mičetić-Turk Dušanka; Umek Bradač Stanislava; Gorenjak Maksimiljan
    Ultrasonographic (US) assessment of coeliac disease (CD) in children
    1996
  35. Arvikar Sheila; Collier Deborah S; Fisher Mark C; Unizony Sebastian; Cohen George L; McHugh Gail; Kawai Toshihisa; Strle Klemen; Steere Allen C.
    Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis
    2013
  36. Londoño Diana; Cadavid Diego; Drouin Elise E.; Strle Klemen; McHugh Gail; Aversa John; Steere Allen C.
    Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory lyme arthritis
    2014
  37. Crowley Jameson T.; Drouin Elise E.; Pianta Annalisa; Strle Klemen; Wang Qi; Costello Catherine E.; Steere Allen C.
    A highly expressed human protein, apolipoprotein B-100, serves as an autoantigen in a subgroup of patients with lyme disease
    2015
  38. Pianta Annalisa; Drouin Elise E.; Crowley Jameson T.; Arvikar Sheila; Strle Klemen; Costello Catherine E.; Steere Allen C.
    Annexin A2 is a target of autoimmune T and B cell responses associated with synovial fibroblast proliferation in patients with antibiotic-refractory Lyme arthritis
    2015
  39. Darcis Gilles; Kula Anna; Bouchat Sophie; Fujinaga Koh; Corazza Francis; Ait-Ammar Amina; Delacourt Nadège; Melard Adeline; Kabeya Kabamba; Peterlin Matija Boris
    An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression
    2015
  40. Kenda Jana; Kojović Maja; Graus F.; Gregorič Kramberger Milica
    (Pseudo)hemidystonia associated with anti-glutamic acid decarboxylase antibodies
    2015
  41. Mekinian Arsene; Ambrožič Aleš; Avčin Tadej
    Mothers' antiphospholipid antibodies during pregnancy and the relation to offspring outcome
    2014
  42. Roncador Giovanna; Engel Pablo; Maestre Lorena; Anderson Amanda P.; Cordell Jacqueline L.; Cragg Mark S.; Čurin-Šerbec Vladka; Jones Margaret; Juranić Lisnić Vanda; Kremer Leonor
    The European antibody network's practical guide to finding and validating suitable antibodies for research
    2016
  43. Homšak Matjaž; Koren Brigita; Tomazin Maja; Brunčko Aleksander
    Mehanizmi imunoterapije z alergeni apliciranimi pod jezik (SLIT)
    2008
  44. Božič Mojca; Boc Vinko; Salapura Vladka; Blinc Aleš; Stegnar Mojca
    Is restenosis/reocclusion after femoropopliteal percutaneous transluminal angioplasty (PTA) the consequence of reduced blood flow, inflammation, and/or hemostasis disturbances?
    2015
  45. Mesti Tanja; Hlebanja Zvezdana; Reberšek Martina; Volk Neva; Benedik Jernej; Boc Marko; Ocvirk Janja
    Joint pain in patients with metastatic colorectal cancer (mCRC) treated with bevacizumab
    2009
  46. Fikfak Nataša; Mesti Tanja
    Zdravljenje diseminiranega plazmocitoma z bortezomibom
    2008
  47. Ocvirk Janja
    Sistemsko zdravljenje raka debelega črevesa in danke
    [Sistemic treatment of colorectal cancer]
    2009
  48. Grašič-Kuhar Cvetka; Čufer Tanja; Golouh Rastko
    Highly effective treatment with trastuzumab in a chemotherapy-resistant metastatic breast carcinoma
    2002
  49. Glišovič Maša; Mršnik Marina; Zupanič Slavec Zvonka
    Celiakija - spoznavanje bolezni v svetu in pri Slovencih
    [The evolution of coeliac disease]
    2015
  50. Žigon Polona; Čučnik Saša; Ambrožič Aleš; Sodin-Šemrl Snežna
    Diagnostic efficacy of antiphosphatidylserine/prothrombin antibodies (aPS/PT) for antiphospholipid syndrome
    2012
  51. Ciuleanu Tudor; Ocvirk Janja
    A randomized, open-label CECOG phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC)
    2008
  52. Mesti Tanja; Ocvirk Janja
    Evaluation of the glioblastoma cell lines response to arsenic trioxide (As [sub] 2O [sub] 3) and bevacizumab according to the IDH1 mutation status
    [Odgovor glioblastomskih celičnih linij na arzenov trioksid (As [spodaj] 2O [spodaj] 3) in bevacizumab glede na prisotnost IDH1 mutacije]
    2015
  53. Gardašević Topčić Ivana; Jaki Polona; Pahor Dušica
    Učinki intravitrealnega bevacizumaba na morfologijo in delovanje mrežnice pri zdravljenju zapore centralne mrežnične vene
    2015
  54. Lanišnik-Rižner Tea; Sasano Hironobou; Choi Man Ho; Odermatt Alex; Adamski Jerzy
    Recommendations for description and validation for antibodies for research use
    2015
  55. Žigon Polona; Božič Mojca; Frank Mojca; Ambrožič Aleš; Tomšič Matija; Hočevar Alojzija; Božič Borut; Sodin-Šemrl Snežna; Kveder Tanja; Čučnik Saša
    Laboratory methodology important in the diagnosis and prognosis of antiphospholipid syndrome
    2015
  56. Štrbenc Malan; Smerdu Vika; Županc Manca; Tozon Nataša; Fazarinc Gregor
    Pattern of myosin heavy chain isoforms in different fibre types of canine trunk and limb skeletal muscles
    2004
  57. Lotrič-Furlan Stanka; Rojko Tereza; Jelovšek Mateja; Petrovec Miroslav; Avšič-Županc Tatjana; Lusa Lara; Strle Franc
    Comparison of clinical and laboratory characteristics of patients fulfilling criteria for proven and probable human granulocytic anaplasmosis
    2015
  58. Lelli Davide; Moreno Ana; Steyer Andrej; Naglič Tina; Chiapponi Chiara; Prosperi Alice; Faccin Francesca; Sozzi Enrica; Lavazza Antonio
    Detection and characterization of a novel reassortant mammalian orthoreovirus in bats in Europe
    2015
  59. Rozman Blaž
    The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis
    2009
  60. Agmon-Levin Nancy; Rozman Blaž
    Prevalence of hepatitis C serum antibody in autoimmune diseases
    2009
  61. Irman Špela; Škarabot Miha; Muševič Igor; Rozman Blaž; Božič Borut
    The use of atomic force microscopy to study the pathologic effects of anti-annexin autoantibodies
    2011
  62. Sonc Monika
    Biološka zdravila v terapiji raka dojke in ostalih rakih
    2009
  63. Borštnar Simona
    Monoklonska protitelesa v zdravljenju raka dojk
    [Monoclonal antibodies for the treatment of breast cancer]
    2015
  64. Davceva Natasha; Basheska Neli; Balažic Jože
    Diffuse axonal injury - a distinct clinicopathological entity in closed head injuries
    2015
  65. Rajić Vladan; Debeljak Maruša; Goričar Katja; Jazbec Janez
    Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia
    2015
  66. Tepeš Bojan
    Population based Helicobacter pylori screening and eradication
    2014
  67. Podgoršek Daša; Cerar Kišek Tjaša; Logar Mateja; Lešničar Gorazd; Remec-Zafred Tatjana; Baklan Zvonko; Pal Emil; Ružić-Sabljić Eva
    Evaluation of the immunochromatographic (Leptocheck) test for detection of specific antibodies against leptospires
    2015
  68. Pinheiro C.; Roque R.; Adriano A.; Mendes P.; Praça M.; Reis I.; Pereira T.; Srebotnik-Kirbiš Irena; André S.
    Optimization of immunocytochemistry in cytology
    2015
  69. Pečovnik-Balon Breda; Ekart Robert; Gorenjak Maksimiljan
    Fibroblastni rastni faktor 23 in kronična ledvična bolezen
    [Fibroblast growth factor 23 in chronic kidney disease]
    2013
  70. Urlep Žužej Darja; Dolinšek Jernej; Mičetić-Turk Dušanka
    Pomen določanja protiteles proti eksokrinemu delu pankreasa (PAB) pri otrocih in mladostnikih s Crohnovo boleznijo
    2010
  71. Dolinšek Jernej; Krenčnik Tomaž
    Serološki testi in celiakija
    2008
  72. Žigon Polona; Ambrožič Aleš; Tomšič Matija; Sodin-Šemrl Snežna; Čučnik Saša
    IgA anti-phosphatidylserin/prothrombin antibodies present a thrombotic risk in patients with systemic autoimmune diseases
    2015
  73. Gašperšič Nataša; Zaletel Marjan; Kobal Jan; Žigon Polona; Čučnik Saša; Sodin-Šemrl Snežna; Tomšič Matija; Ambrožič Aleš
    Antiphospholipid antibodies in patients with cerebrovascular events
    2015
  74. Pišec Natalija; Arnol Miha; Montanič Sendi; Kandus Aljoša; Vidan-Jeras Blanka
    Clinical relevance of the luminex based cross-match and SA test in deceased donor kidney transplantation
    2015
  75. Stopinšek Sanja; Simčič Saša; Thoresen Marianne
    Autoimmune encephalitis and antibodies against neuronal cell antigens
    2015
  76. Janier M.; Hegyi V.; Dupin N.; Unemo Magnus; Tiplica G. S.; Potočnik Marko; French P.; Patel R.
    2014 European guideline on the management of syphilis
    2014
  77. Gruson Damien; Homšak Evgenija
    Measurement of anti-Mullerian hormone
    2015
  78. Costa Stefano; Astarita Luca; Hariz M. Ben; Currò Giovanni; Dolinšek Jernej; Kansu Aydan; Magazzu Giuseppe; Marvaso Stefania; Mičetić-Turk Dušanka; Pellegrino Salvatore; Primavera Giuseppe; Rossi Pasqualino; Smarrazzo Andrea; Tucci Francesca; Arcidiaco Carmela; Greco Luigi
    A point-of-care test for facing the burden of undiagnosed celiac disease in the Mediterranean area: a pragmatic design study
    2014
  79. Žigon Polona; Ambrožič Aleš; Božič Borut; Čučnik Saša
    Protitelesa proti protrombinu
    [Antiprothrombin antibodies]
    2015
  80. Urlep Žužej Darja; Dolinšek Jernej; Mičetić-Turk Dušanka
    Pancreatic antibodies are associated with anti-saccharomyces cerevisiae antibodies and more complicated disease phenotype in paediatric Crohn's disease
    2011
  81. Škulj Mihaela; Zorec Robert; Kreft Marko
    Mehanizem izločanja rekombinantnih proteinov iz celičnih linij ovarijskih celic kitajskega hrčka (CHO)
    [The Mechanism of exocytosis of reco[m]binant proteins from chinese hamster ovary (CHO) cells]
    2015
  82. Švec Tinka; Božič Borut; Kveder Tanja
    Uvedba metode za določanje protiteles proti dvojnoverižni DNA z uporabo neradioaktivnih reagentov
    [Implementation of a nonradioactive method for determination of autoantibodies against doublestranded DNA]
    2014
  83. Andreoli Laura; Nalli Cecilia; Motta M.; Norman Gary L.; Shums Zakera; Encabo Susan; Binder Walter L; Nuzzo Monica; Frassi M.; Lojacono A.; Avčin Tadej; Meroni PierLuigi; Tincani A.
    Anti-[beta]2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5
    2011
  84. Kenda Jana; Švigelj Viktor; Rodi Zoran; Koritnik Blaž; Graus F.; Kojović Maja
    Glycine receptor antibodies and progressive encephalomyelitis with rigidity and myoclonus with predominant motor neuron degeneration-expanding the clinical spectrum
    2015
  85. Aguiar Cassyanne L.; Soybilgic Arzu; Avčin Tadej; Myones Barry L.
    Pediatric antiphospholipid syndrome
    2015
  86. Čorović Selma; Markelc Boštjan; Dolinar Mitja; Čemažar Maja; Jarm Tomaž
    Modeling of microvascular permeability changes after electroporation
    2015
  87. Sodin-Šemrl Snežna
    Serum amyloid A and its autoantibodies
    2015
  88. Žigon Polona; Perdan-Pirkmajer Katja; Tomšič Matija; Kveder Tanja; Božič Borut; Sodin-Šemrl Snežna; Čučnik Saša; Ambrožič Aleš
    Anti-phosphatidylserine/prothrombin antibodies are associated with adverse pregnancy outcomes
    2015
  89. Kveder Tanja; Lakota Katja; Švec Tinka; Čučnik Saša; Žigon Polona; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Tomšič Matija
    Fluorometric immunoassay for detection of anti-dsDNA antibodies
    2015
  90. Artenjak Andrej; Omersel Jasna; Ahlin Grabnar Pegi; Mlinarič-Raščan Irena; Shoenfeld Yehuda; Sodin-Šemrl Snežna; Božič Borut; Čučnik Saša
    Oxidatively altered IgG with increased immunoreactivity to [beta]2-glycoprotein I and its peptide clusters influence human coronary artery endothelial cells
    2015
  91. Didonna Alessandro; Colja Venturini Anja; Pretnar-Hartman Katrina; Vranac Tanja; Čurin-Šerbec Vladka; Legname Giuseppe
    Characterization of four new monoclonal antibodies against the distal N-terminal region of PrPc
    2015
  92. Van den Bemt B J F; Rozman Blaž
    A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis
    2009
  93. Štrukelj Borut
    Biološka zdravila pri multipli sklerozi
    [Biological medicinal products in the treatment of multiple sclerosis]
    2015
  94. Artenjak Andrej; Locatelli Igor; Brelih Hana; Simonič Darka Maša; Ulčová-Gallová Zdenka; Swadzba J; Musial J; Iwaniec T; Stojanović Ljudmila; Conti F.; Valesini Guido; Avčin Tadej; Cohen Tervaert JW; Shoenfeld Yehuda; Blank Miri; Ambrožič Aleš; Sodin-Šemrl Snežna; Božič Borut; Čučnik Saša
    Immunoreactivity and avidity of IgG anti-ß2- glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of ß2-glycoprotein I
    2014
  95. Omersel Jasna; Božič Borut
    Avtoimunost - mehanizmi in pomen redoks procesov
    [Autoimmunity - mechanisms and significance of redox processes]
    2010
  96. Hrast Martina; Obreza Aleš
    Vloga silicijevih spojin v živih organizmih
    [The role of silicon compounds in living organisms]
    2010
  97. Rojnik Matija; Kos Janko
    Fotodinamično zdravljenje raka
    [Photodynamic therapy of cancer]
    2010
  98. Jezeršek Novaković Barbara; Horvat Mateja; Kloboves-Prevodnik Veronika; Novaković Srdjan
    The intensity of CD20 expression determines the outcome of rituximab treatment
    2010
  99. Ocvirk Janja
    Anti-angiogenic therapy for malignant gliomas
    2009
  100. Jezeršek Novaković Barbara; Benigar Ana; Novaković Srdjan
    Single centre experience with rituximab treatment in NonHodgkin's lymphoma patients
    2009

   1 101 201 301 401 501 601 701 801 901  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics